Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Royal Brompton Hospital, Imperial College London, Duke University, Duke Medical Center, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, University of Cambridge, Bridge University, Cambridge School, NIHR Cambridge Biomedical Research Centre, Mount Sinai Health System, Sinai Health System, Sinai Health System, Mount Sinai Hospital, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Federico II University Hospital, Vanderbilt University Medical Center, Harvard University, Brigham and Women's Hospital, Medical University of Vienna, The University of Melbourne, Monash Medical Centre, Institute of Cancer Research, Monash University, National University Health System, National University Heart Centre Singapore, Berlin-Brandenburger Centrum für Regenerative Therapien, Charité - Universitätsmedizin Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, German Centre for Cardiovascular Research, University of Göttingen, Goa Medical College, University of Würzburg, Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Charles University, University Hospital Hradec Králové, Georgetown University, MedStar Heart & Vascular Institute, Ted Rogers Centre for Heart Research, University of Toronto, University Health Network, Toronto General Hospital, University of Pennsylvania, Massachusetts General Hospital, Sechenov University, Tel Aviv University, University of Newcastle Australia, Hunter New England Local Health District, Sociedade Brasileira de Cardiologia, Universidade de São Paulo, Santa Casa Hospital, University College London, British Heart Foundation, University of Campania "Luigi Vanvitelli", University of Campania "Luigi Vanvitelli", University of Cyprus, National and Kapodistrian University of Athens, University of Nicosia, University of Groningen, University Medical Center Groningen, American University of Beirut Medical Center, University Hospital of Bern, University of Bern, European Institute of Oncology, Stanford University, Mayo Clinic in Arizona, Mayo Clinic, Mayo Clinic in Florida, Amyloidosis Foundation, Memorial Sloan Kettering Cancer Center, Hammersmith Hospital, King's College Hospital, University Hospital of Zurich, Zurich Heart House, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, IRCCS Ospedale San Raffaele, University of Warwick, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, Serbian Academy of Sciences and Arts, University of Belgrade, University of Arts in Belgrade, Carol Davila University of Medicine and Pharmacy, Institutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu", Medizinische Hochschule Hannover, University of Liverpool, Liverpool Heart and Chest Hospital, Hospital La Paz Institute for Health Research, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle University, Washington University in St. Louis